Peptide vaccines incorporating B- and T-cell epitopes have shown promise in the context of various cancers infections. These are relatively simple to manufacture, but more immunogenic formulations considered a priority. We developed tetrabranched derivatives for this purpose based on novel peptide welding technology (PWT). PWTs provide molecular scaffolds efficient synthesis ultrapure dendrimer...

Epitope tags are widely used in cell biology and biochemistry research. The S-peptide/S-protein interaction has previously been utilized to purify polypeptides expressed in bacteria. We have now re-engineered the S-peptide/S-protein system to allow isolation of S-peptide-tagged polypeptides and their binding partners from eukaryotic cells with S-protein-agarose. In addition, two anti-S-peptide ...

Background: The papaya mosaic virus (PapMV) vaccine platform is a rod-shaped nanoparticle made of the recombinant PapMV coat protein (CP) self-assembled around noncoding single-stranded RNA (ssRNA) template. induces innate immunity through stimulation Toll-like receptors (TLR) 7 and 8. display antigen at surface nanoparticle, associated with co-stimulation signal via TLR7/8, ensures strong immu...

Three custom synthesized myelin basic protein (MBP) peptides, bovine peptide 79-88, human peptide 80-89, and human peptide 82-91, were used to produce four murine monoclonal antibodies (MAb) that were selected on the basis of reaction in a solid phase radioimmunoassay (SRIA) with human MBP. The MAb were compared with respect to antigen specificity against intact MBP and 10 overlapping MBP pepti...

....................................................................................................................................................... 79 INTRODUCTION ................................................................................................................................................. 80 NUMBER OF ANTIGENIC DETERMINANTS ON β1-Bgt ........................................

Efficient loading of MHC class II molecules with a T helper epitope of choice can be achieved through genetic exchange of the MHC class II-associated invariant chain peptide (CLIP) sequence with a sequence encoding the helper peptide. We have now used this method to engineer a cellular vaccine that continuously expresses a tumor-specific helper epitope in a defined costimulatory context. We pro...

• Increased T-cell responses after targeting antigen to antigen-presenting cells. Antibody:T-cell epitope fusion mode affects the strength of response. integration supports induction CD4 and CD8 responses. Targeted delivery cells (APCs) enhances presentation thus, is a potent strategy for making more efficacious vaccines. This can be achieved by use antibodies with specificity endocytic surface...

Identification of peptides that can bind to major histocompatibility complex (MHC) molecules is important for anticipation of T-cell epitopes and for the design of epitope-based vaccines. Population coverage of epitope vaccines is, however, compromised by the extreme polymorphism of MHC molecules, which is in fact the basis for their differential peptide binding. Therefore, grouping of MHC mole...

The interferon gamma, enzyme-linked immunospot (IFN-γ ELISpot) assay is widely used to identify viral antigen-specific T cells is frequently employed to quantify T cell responses in HIV vaccine studies. It can be used to define T cell epitope specificities using panels of peptide antigens, but with sample and cost constraints there is a critical need to improve the efficiency of epitope mapping...

The human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 4E10 binds to a linear, highly conserved epitope within the membrane-proximal external region of the HIV-1 envelope glycoprotein gp41. We have delineated the peptide epitope of the broadly neutralizing 4E10 antibody to gp41 residues 671 to 683, using peptides with different lengths encompassing the previously suggested core e...